Vaccinex OverviewVaccinex Research & Development
Research & Development expenses for VCNX.
Quarterly R&D Expenses
$2.13M
↓ 35.96% YoY
As of Dec 31, 2024
Annual R&D Expenses (TTM)
$12.52M
↓ 24.34% YoY
Trailing 12 months ending Dec 31, 2024
Vaccinex OverviewResearch & Development expenses for VCNX.
As of Dec 31, 2024
Trailing 12 months ending Dec 31, 2024